
Ondine Biomedical pauses trading to raise funds after positive phase III trial for nasal infection treatment
Ondine Biomedical has suspended trading to raise new investment following successful phase III trial results for its Steriwave nasal disinfection product, which reduced surgical site infections by 40.5%. The funds will support publishing trial result...





